Holen Sie sich die Stockscreener-App
9.15
1.08%
-0.10
Schlusskurs vom Vortag:
$9.25
Offen:
$9.27
24-Stunden-Volumen:
147.23K
Relative Volume:
1.41
Marktkapitalisierung:
$149.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.3576
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
-6.06%
1M Leistung:
-17.12%
6M Leistung:
+66.36%
1J Leistung:
+98.48%
1-Tages-Spanne:
$9.07
$9.60
1-Wochen-Bereich:
$9.00
$9.81
52-Wochen-Spanne:
$4.60
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Firmenname
Elicio Therapeutics Inc
Sektor
Branche
Telefon
(857) 209-0050
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Vergleichen Sie ELTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
9.15 | 151.13M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Using economic indicators to assess Elicio Therapeutics Inc. potentialJuly 2025 Update & Weekly Stock Breakout Alerts - newser.com
How Elicio Therapeutics Inc. stock compares to market leadersMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulationsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
How high can Elicio Therapeutics Inc. stock goEarnings Recap Report & Smart Money Movement Tracker - newser.com
Can Elicio Therapeutics Inc. stock outperform in 2025 bull market2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Will Elicio Therapeutics Inc. outperform the marketMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Elicio Therapeutics Inc. stock trendline breakdown2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Analyzing net buyer seller activity in Elicio Therapeutics Inc.Weekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Analyzing drawdowns of Elicio Therapeutics Inc. with statistical toolsWeekly Stock Report & High Return Trade Guides - newser.com
Statistical indicators supporting Elicio Therapeutics Inc.’s strengthJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
How Elicio Therapeutics Inc. (9HA) stock moves in volatile trading sessionsMarket Sentiment Report & Daily Volume Surge Signals - newser.com
Elicio (NASDAQ: ELTX) to present late-breaking Phase 2 ELI-002 data at SITC 2025 - Stock Titan
Key metrics from Elicio Therapeutics Inc.’s quarterly dataMarket Rally & Low Drawdown Investment Ideas - newser.com
Is Elicio Therapeutics Inc. stock oversold or undervalued2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is Elicio Therapeutics Inc. (9HA) stock bottoming after sell offBull Run & Expert-Curated Trade Recommendations - newser.com
What valuation multiples suggest for Elicio Therapeutics Inc. stockMarket Volume Report & Safe Swing Trade Setups - newser.com
Can Elicio Therapeutics Inc. (9HA) stock attract ESG investmentsEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Can Elicio Therapeutics Inc. stock weather global recessionQuarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
Is Elicio Therapeutics Inc. stock attractive for hedge funds2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
Elicio Therapeutics, Inc. (ELTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What earnings revisions data tells us about Elicio Therapeutics Inc.Weekly Gains Report & Capital Efficient Trade Techniques - newser.com
Is Elicio Therapeutics Inc. stock poised for growthFed Meeting & Risk Managed Investment Entry Signals - newser.com
Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):